These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7631546)

  • 21. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
    Marsan C; Gaulier A; Sabatier P; Garcia R
    Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey.
    Hallman JR; Geisinger KR
    Acta Cytol; 1994; 38(2):209-17. PubMed ID: 8147212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of C-reactive protein in effusions in dogs.
    Parra MD; Papasouliotis K; Cerón JJ
    Vet Rec; 2006 Jun; 158(22):753-7. PubMed ID: 16751309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
    Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
    Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of immunoperoxidase staining in serous effusions.
    Sarker AB; Hoshida Y; Nose S
    Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of pericellular lacunae in cell blocks of effusions.
    Price BA; Ehya H; Lee JH
    Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of clot examination for malignant cells in serous effusions.
    Jalal R; Aftab K; Hasan SH; Pervez S
    Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkaline phosphatase in pleural effusions.
    Lone MA; Wahid A; Saleem SM; Koul P; Dhobi GN; Shahnawaz A
    Indian J Chest Dis Allied Sci; 2003; 45(3):161-3. PubMed ID: 12866632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions].
    Daste G; Gioanni J; Lauque D; Kremps M; Mazeau C; Paquis P; Schneider M
    Arch Anat Cytol Pathol; 1997; 45(4):185-91. PubMed ID: 9406475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of immunocytochemistry in differentiating benign and malignant serous effusion].
    Mei P; Luo XL; Liu YH; Zhuang HG; Zhang W; Chen GY
    Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):368-9. PubMed ID: 16185510
    [No Abstract]   [Full Text] [Related]  

  • 35. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM; Stern R; Michael CW
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology.
    Singh G; Dekker A; Ladoulis CT
    Acta Cytol; 1978; 22(6):487-9. PubMed ID: 282748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of p53 protein and flow cytometric DNA analysis in the study of serous effusions.
    Lee JS; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1997; 41(6):1719-25. PubMed ID: 9390131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.